-
2
-
-
0141853344
-
Tuberculosis
-
Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet. 2003;362(9387):887-99.
-
(2003)
Lancet
, vol.362
, Issue.9387
, pp. 887-899
-
-
Frieden, T.R.1
Sterling, T.R.2
Munsiff, S.S.3
Watt, C.J.4
Dye, C.5
-
3
-
-
30444441465
-
The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis
-
Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med. 2005;172(12):1487-90.
-
(2005)
Am. J. Respir. Crit. Care Med.
, vol.172
, Issue.12
, pp. 1487-1490
-
-
Gelperina, S.1
Kisich, K.2
Iseman, M.D.3
Heifets, L.4
-
4
-
-
0032726452
-
Treatment and prevention of multidrug-resistant tuberculosis
-
Bastian I, Colebunders R. Treatment and prevention of multidrug-resistant tuberculosis. Drugs. 1999;58(4):633-61.
-
(1999)
Drugs
, vol.58
, Issue.4
, pp. 633-661
-
-
Bastian, I.1
Colebunders, R.2
-
5
-
-
33646822975
-
Advances in tuberculosis vaccine strategies
-
Skeiky YA, Sadoff JC. Advances in tuberculosis vaccine strategies. Nat Rev Microbiol. 2006;4(6):469-76.
-
(2006)
Nat. Rev. Microbiol.
, vol.4
, Issue.6
, pp. 469-476
-
-
Skeiky, Y.A.1
Sadoff, J.C.2
-
6
-
-
0031901988
-
Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients
-
Kimerling ME, Phillips P, Patterson P, Hall M, Robinson CA, Dunlap NE. Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients. Chest. 1998;113(5):1178-83.
-
(1998)
Chest
, vol.113
, Issue.5
, pp. 1178-1183
-
-
Kimerling, M.E.1
Phillips, P.2
Patterson, P.3
Hall, M.4
Robinson, C.A.5
Dunlap, N.E.6
-
7
-
-
0035991699
-
Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid
-
Conte Jr JE, Golden JA, McQuitty M, Kipps J, Duncan S, McKenna E et al. Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid. Antimicrob Agents Chemother. 2002;46(8):2358-64.
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, Issue.8
, pp. 2358-2364
-
-
Conte Jr., J.E.1
Golden, J.A.2
McQuitty, M.3
Kipps, J.4
Duncan, S.5
McKenna, E.6
-
8
-
-
23244459431
-
Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana
-
Tappero JW, Bradford WZ, Agerton TB, Hopewell P, Reingold AL, Lockman S et al. Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana. Clin Infect Dis. 2005;41(4):461-9.
-
(2005)
Clin. Infect. Dis.
, vol.41
, Issue.4
, pp. 461-469
-
-
Tappero, J.W.1
Bradford, W.Z.2
Agerton, T.B.3
Hopewell, P.4
Reingold, A.L.5
Lockman, S.6
-
9
-
-
70350228508
-
Inhaled drug delivery for tuberculosis therapy
-
Muttil P, Wang C, Hickey AJ. Inhaled drug delivery for tuberculosis therapy. Pharm Res. 2009;26:2401-16.
-
(2009)
Pharm. Res.
, vol.26
, pp. 2401-2416
-
-
Muttil, P.1
Wang, C.2
Hickey, A.J.3
-
10
-
-
46549090057
-
Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan micro-spheres for the treatment of tuberculosis
-
Hwang SM, Kim DD, Chung SJ, Shim CK. Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan micro-spheres for the treatment of tuberculosis. J Control Release. 2008;129(2):100-6.
-
(2008)
J. Control Release
, vol.129
, Issue.2
, pp. 100-106
-
-
Hwang, S.M.1
Kim, D.D.2
Chung, S.J.3
Shim, C.K.4
-
11
-
-
0037436978
-
A novel method for assessing dissolution of aerosol inhaler products
-
Davies NM, Feddah MR. A novel method for assessing dissolution of aerosol inhaler products. Int J Pharm. 2003;255(1-2):175-87.
-
(2003)
Int. J. Pharm.
, vol.255
, Issue.1-2
, pp. 175-187
-
-
Davies, N.M.1
Feddah, M.R.2
-
13
-
-
3042545961
-
Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: Effects of molecular weight and composition of PLGA on release of rifampicin
-
Makino K, Nakajima T, Shikamura M, Ito F, Ando S, Kochi C et al. Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin. Colloids Surf B Biointerfaces. 2004;36(1):35-42.
-
(2004)
Colloids Surf B. Biointerfaces
, vol.36
, Issue.1
, pp. 35-42
-
-
Makino, K.1
Nakajima, T.2
Shikamura, M.3
Ito, F.4
Ando, S.5
Kochi, C.6
-
14
-
-
0032930265
-
Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis
-
Phetsuksiri B, Baulard AR, Cooper AM, Minnikin DE, Douglas JD, Besra GS et al. Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis. Antimicrob Agents Chemother. 1999;43(5):1042-51.
-
(1999)
Antimicrob. Agents Chemother.
, vol.43
, Issue.5
, pp. 1042-1051
-
-
Phetsuksiri, B.1
Baulard, A.R.2
Cooper, A.M.3
Minnikin, D.E.4
Douglas, J.D.5
Besra, G.S.6
-
15
-
-
0013796972
-
-
Isoxyl. Tubercle. 1965;46(3):298-300.
-
(1965)
Tubercle
, vol.46
, Issue.3
, pp. 298-300
-
-
Isoxyl1
-
16
-
-
0014886149
-
On the clinical effectiveness of isoxyl
-
Tousek J. On the clinical effectiveness of isoxyl. Antibiot Chemother. 1970;16:149-55.
-
(1970)
Antibiot. Chemother.
, vol.16
, pp. 149-155
-
-
Tousek, J.1
-
17
-
-
83955164932
-
-
Bartmann K, editor Berlin: Springer-Verlag
-
Bartmann K, editor. Antituberculosis drugs. Berlin: Springer-Verlag; 1988. p. 185-9.
-
(1988)
Antituberculosis Drugs
, pp. 185-189
-
-
-
19
-
-
34547150620
-
Preparation of ultrafine beclomethasone dipropionate drug powder by antisolvent precipitation
-
Wang Z, Chen JF, Le Y, Shen ZG, Yun J. Preparation of ultrafine beclomethasone dipropionate drug powder by antisolvent precipitation. Ind Eng Chem Res. 2007;46(14):4839-45.
-
(2007)
Ind. Eng. Chem. Res.
, vol.46
, Issue.14
, pp. 4839-4845
-
-
Wang, Z.1
Chen, J.F.2
Le, Y.3
Shen, Z.G.4
Yun, J.5
-
20
-
-
33845906339
-
Inhaling medicines: Delivering drugs to the body through the lungs
-
Patton JS, Byron PR. Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov. 2007;6(1):67-74.
-
(2007)
Nat. Rev. Drug Discov.
, vol.6
, Issue.1
, pp. 67-74
-
-
Patton, J.S.1
Byron, P.R.2
-
21
-
-
47949090122
-
Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution
-
Tam JM, McConville JT, Williams 3rd RO, Johnston KP. Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution. J Pharm Sci. 2008;97:4915-33.
-
(2008)
J. Pharm. Sci.
, vol.97
, pp. 4915-4933
-
-
Tam, J.M.1
McConville, J.T.2
Williams III, R.O.3
Johnston, K.P.4
-
22
-
-
0037133126
-
Targeting to macrophages: Role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages
-
Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages. J Control Release. 2002;79(1-3):29-40.
-
(2002)
J. Control Release
, vol.79
, Issue.1-3
, pp. 29-40
-
-
Ahsan, F.1
Rivas, I.P.2
Khan, M.A.3
Suarez, A.I.T.4
-
23
-
-
0034781469
-
Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis
-
Sharma R, Saxena D, Dwivedi AK, Misra A. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis. Pharm Res. 2001;18(10):1405-10.
-
(2001)
Pharm. Res.
, vol.18
, Issue.10
, pp. 1405-1410
-
-
Sharma, R.1
Saxena, D.2
Dwivedi, A.K.3
Misra, A.4
-
24
-
-
34248155773
-
Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra
-
Sharma R, Muttil P, Yadav AB, Rath SK, Bajpai VK, Mani U et al. Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra. J Antimicrob Chemother. 2007;59(3):499-506.
-
(2007)
J. Antimicrob. Chemother.
, vol.59
, Issue.3
, pp. 499-506
-
-
Sharma, R.1
Muttil, P.2
Yadav, A.B.3
Rath, S.K.4
Bajpai, V.K.5
Mani, U.6
-
25
-
-
47949090122
-
Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution
-
Tam JM, McConville JT, Williams 3rd RO, Johnston KP. Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution. J Pharm Sci. 2008;97(11):4915-33.
-
(2008)
J. Pharm. Sci.
, vol.97
, Issue.11
, pp. 4915-4933
-
-
Tam, J.M.1
McConville, J.T.2
Williams III, R.O.3
Johnston, K.P.4
-
26
-
-
33750325780
-
Drug nanoparticles by antisolvent precipitation: Mixing energy versus surfactant stabilization
-
Matteucci ME, Hotze MA, Johnston KP, Williams 3rd RO. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir. 2006;22(21):8951-9.
-
(2006)
Langmuir
, vol.22
, Issue.21
, pp. 8951-8959
-
-
Matteucci, M.E.1
Hotze, M.A.2
Johnston, K.P.3
Williams III, R.O.4
-
27
-
-
0004294969
-
-
4th ed. Oxford: Butterworth-Heinemann
-
Mullin JW. Crystallization. 4th ed. Oxford: Butterworth-Heinemann; 2001.
-
(2001)
Crystallization
-
-
Mullin, J.W.1
-
29
-
-
35248815576
-
Antisolvent crystallization of sulfa drugs and the effect of process parameters
-
Park SJ, Yeo SD. Antisolvent crystallization of sulfa drugs and the effect of process parameters. Sep. Sci Technol. 2007;42:2645-60.
-
(2007)
Sep. Sci. Technol.
, vol.42
, pp. 2645-2660
-
-
Park, S.J.1
Yeo, S.D.2
-
30
-
-
74049124897
-
Spray drying technique. I: Hardware and process parameters
-
Cal K, Sollohub K. Spray drying technique. I: Hardware and process parameters. J Pharm Sci. 2010;99:575-86.
-
(2010)
J. Pharm. Sci.
, vol.99
, pp. 575-586
-
-
Cal, K.1
Sollohub, K.2
-
31
-
-
0037433847
-
The influence of carrier and drug morphology on drug delivery from dry powder formulations
-
Larhrib H, Martin GP, Marriott C, Prime D. The influence of carrier and drug morphology on drug delivery from dry powder formulations. Int J Pharm. 2003;257(1-2):283-96.
-
(2003)
Int. J. Pharm.
, vol.257
, Issue.1-2
, pp. 283-296
-
-
Larhrib, H.1
Martin, G.P.2
Marriott, C.3
Prime, D.4
-
32
-
-
0019846414
-
Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals
-
Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E et al. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst. 1981;67(5):965-75.
-
(1981)
J. Natl. Cancer Inst.
, vol.67
, Issue.5
, pp. 965-975
-
-
Stanton, M.F.1
Layard, M.2
Tegeris, A.3
Miller, E.4
May, M.5
Morgan, E.6
-
33
-
-
0024352294
-
Multiple mechanisms for the carcinogenic effects of asbestos and other mineral fibers
-
Barrett JC, Lamb PW, Wiseman RW. Multiple mechanisms for the carcinogenic effects of asbestos and other mineral fibers. Environ Health Perspect. 1989;81:81-9.
-
(1989)
Environ. Health Perspect.
, vol.81
, pp. 81-89
-
-
Barrett, J.C.1
Lamb, P.W.2
Wiseman, R.W.3
-
34
-
-
0031655975
-
Effect of fiber length on glass microfiber cytotoxicity
-
Blake T, Castranova V, Schwegler-Berry D, Baron P, Deye GJ, Li C et al. Effect of fiber length on glass microfiber cytotoxicity. J Toxicol Environ Health A. 1998;54(4):243-59.
-
(1998)
J. Toxicol. Environ. Health A
, vol.54
, Issue.4
, pp. 243-259
-
-
Blake, T.1
Castranova, V.2
Schwegler-Berry, D.3
Baron, P.4
Deye, G.J.5
Li, C.6
-
35
-
-
33646537193
-
In vitro cytotoxicity of manville code 100 glass fibers: Effect of fiber length on human alveolar macrophages
-
Zeidler-Erdely PC, Calhoun WJ, Ameredes BT, Clark MP, Deye GJ, Baron P et al. In vitro cytotoxicity of Manville Code 100 glass fibers: effect of fiber length on human alveolar macrophages. Part Fibre Toxicol. 2006;3:5.
-
(2006)
Part Fibre Toxicol.
, vol.3
, pp. 5
-
-
Zeidler-Erdely, P.C.1
Calhoun, W.J.2
Ameredes, B.T.3
Clark, M.P.4
Deye, G.J.5
Baron, P.6
-
36
-
-
67349261427
-
Preparation of microsized spherical aggregates of ultrafine ciprofloxacin particles for dry powder inhalation (DPI)
-
Zhao H, Le Y, Liu H, Hu T, Shen Z, Yun J et al. Preparation of microsized spherical aggregates of ultrafine ciprofloxacin particles for dry powder inhalation (DPI). Powder Technol. 2009;194:81-6.
-
(2009)
Powder Technol.
, vol.194
, pp. 81-86
-
-
Zhao, H.1
Le, Y.2
Liu, H.3
Hu, T.4
Shen, Z.5
Yun, J.6
-
37
-
-
0016588006
-
Characterization of habits and crystalline modification of solids and their pharmaceutical applications
-
Haleblian JK. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J Pharm Sci. 1975;64(8):1269-88.
-
(1975)
J. Pharm. Sci.
, vol.64
, Issue.8
, pp. 1269-1288
-
-
Haleblian, J.K.1
-
38
-
-
42049094490
-
Pharmaceutical particle engineering via spray drying
-
Vehring R. Pharmaceutical particle engineering via spray drying. Pharm Res. 2008;25(5):999-1022.
-
(2008)
Pharm. Res.
, vol.25
, Issue.5
, pp. 999-1022
-
-
Vehring, R.1
-
39
-
-
33847127477
-
Particle engineering for pulmonary drug delivery
-
Chow AH, Tong HH, Chattopadhyay P, Shekunov BY. Particle engineering for pulmonary drug delivery. Pharm Res. 2007;24(3):411-37.
-
(2007)
Pharm. Res.
, vol.24
, Issue.3
, pp. 411-437
-
-
Chow, A.H.1
Tong, H.H.2
Chattopadhyay, P.3
Shekunov, B.Y.4
-
40
-
-
0035937599
-
Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future
-
Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev. 2001;47(1):3-19.
-
(2001)
Adv. Drug Deliv. Rev.
, vol.47
, Issue.1
, pp. 3-19
-
-
Muller, R.H.1
Jacobs, C.2
Kayser, O.3
-
43
-
-
33747025717
-
Symmetrical and unsymmetrical analogues of isoxyl; active agents against Mycobacterium tuberculosis
-
Bhowruth V, Brown AK, Reynolds RC, Coxon GD, Mackay SP, Minnikin DE et al. Symmetrical and unsymmetrical analogues of isoxyl; active agents against Mycobacterium tuberculosis. Bioorg Med Chem Lett. 2006;16(18):4743-7.
-
(2006)
Bioorg Med. Chem. Lett.
, vol.16
, Issue.18
, pp. 4743-4747
-
-
Bhowruth, V.1
Brown, A.K.2
Reynolds, R.C.3
Coxon, G.D.4
Mackay, S.P.5
Minnikin, D.E.6
-
45
-
-
0011489418
-
Dispersion and characterization of pharmaceutical dry powder aerosols
-
Dunbar CA, Hickey AJ, Holzner P. Dispersion and characterization of pharmaceutical dry powder aerosols. KONA. 1998;16:7-44.
-
(1998)
KONA
, vol.16
, pp. 7-44
-
-
Dunbar, C.A.1
Hickey, A.J.2
Holzner, P.3
-
47
-
-
0342657112
-
The influence of carrier morphology on drug delivery by dry powder inhalers
-
Zeng XM, Martin AP, Marriott C, Pritchard J. The influence of carrier morphology on drug delivery by dry powder inhalers. Int J Pharm. 2000;200(1):93-106.
-
(2000)
Int. J. Pharm.
, vol.200
, Issue.1
, pp. 93-106
-
-
Zeng, X.M.1
Martin, A.P.2
Marriott, C.3
Pritchard, J.4
|